CA Intermediate · Advanced Accounting · AS 26 Intangible Assets
Kaveri Pharma Ltd began a project to develop a new drug formulation on 1 April 2025. Costs: Rs 12 lakh in April-August (research phase); Rs 4 lakh in September (development phase, but the AS 26 recognition criteria were not yet demonstrated); and Rs 18 lakh in October-March, by when all the recognition criteria were met from 1 October. What amount should be capitalised as an intangible asset at 31 March 2026, and how much is charged to profit and loss?
Rs 18 lakh is capitalised and Rs 16 lakh is expensed. Research costs of Rs 12 lakh and the Rs 4 lakh development spend before the recognition criteria were met are charged to profit and loss; only spend from 1 October qualifies.
- ACapitalised Rs 18 lakh; charged to profit and loss Rs 16 lakhCorrect
- BCapitalised Rs 22 lakh; charged to profit and loss Rs 12 lakh
- CCapitalised Rs 34 lakh; charged to profit and loss Nil
- DCapitalised Rs 30 lakh; charged to profit and loss Rs 4 lakh
Explanation
Research costs of Rs 12 lakh are always expensed. Development costs are capitalised only from the date all criteria are met (1 October), so the Rs 4 lakh for September is expensed and cannot be reinstated later. Capitalised amount = Rs 18 lakh; expense = 12 + 4 = Rs 16 lakh. Option B wrongly includes September in the asset.
Did you get it right without looking?
One question tells you little. A timed set on AS 26 Intangible Assets shows your real accuracy, how long you take and where you lose marks.
More AS 26 Intangible Assets questions
- Sharma Foods Ltd. incurred the following during the year: advertising campaign Rs 6,00,000; staff training costs Rs 2,50,000; start-up costs…
- Veda Pharma Ltd. incurred Rs 18 lakh on a research phase and Rs 30 lakh on a development phase for a new drug formulation during 2025-26. Th…
- Ravi Ltd. acquired a franchise right by paying Rs 5,00,000 in cash and issuing 10,000 equity shares of face value Rs 10 each, whose fair val…
- Veda Pharma Ltd. spent ₹40 lakh during 2025-26 on a research phase to find a new drug formulation. In the same year it spent ₹25 lakh on an …
- Mehta Foods Ltd. spent Rs 9,00,000 on a national advertising campaign for a new brand and Rs 4,00,000 on staff training for the launch durin…
- Kaveri Pharma Ltd. acquired a patent on 1 April 2023 for Rs 40,00,000 with a legal life of 10 years. Management expects it to generate benef…